HopeStage
Back to all studies
CompletedNCT01765127

Real-World Asenapine Safety in Bipolarity

About this titleRead the official source — NCT01765127
Observational studyUnited Kingdom
The study in practice

Understand this study

Listed locations
SouthamptonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2012
Recruitment status
Completed
Enrollment listed in the registry
122
Sponsor
Professor Saad Shakir
Sponsor type
Individual investigator
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United Kingdom
Age range
Not clearly listed
Official registry ID
NCT01765127
Official title
Show the full official title

An Observational Post-Authorization Modified Prescription-Event Monitoring Safety Study to Monitor the Safety and Utilization of Asenapine (Sycrest) in the Primary Care Setting in England

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Southampton

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Professor Saad Shakir.

Want to explore more studies?

Explore studies